Texcell announces strategic partnership in Japan with Summit Pharmaceuticals International.

Texcell Japan is pleased to announce a strategic partnership in Japan with Summit Pharmaceuticals International (SPI).
SPI has been providing with contract manufacturing, downstream of pharmaceutical manufacturing, and with the addition of Texcell’s services, SPI is able to full-support Japan customers through the pharmaceutical manufacturing processes.

For more information, please download the joint press release